Anti-HBV agents. Part 1: Synthesis of alisol A derivatives: a new class of hepatitis B virus inhibitors.

Anti-HBV agents. Part 1: Synthesis of alisol A derivatives: a new class of hepatitis B virus inhibitors.
复制标题

DOI:
10.1016/j.bmcl.2008.07.012
复制
发表时间:
2008-08
影响因子:
2.7
通讯作者:
Quan Zhang;Zhi-Yong Jiang;Jie Luo;Pi Cheng;Yun-bao Ma;Xue-mei Zhang;Feng-xue Zhang;Jun Zhou;Ji-Jun Chen
Quan Zhang;Zhi-Yong Jiang;Jie Luo;Pi Cheng;Yun-bao Ma;Xue-mei Zhang;Feng-xue Zhang;Jun Zhou;Ji-Jun Chen
中科院分区:
医学4区
文献类型:
--
作者:
Quan Zhang;Zhi-Yong Jiang;Jie Luo;Pi Cheng;Yun-bao Ma;Xue-mei Zhang;Feng-xue Zhang;Jun Zhou;Ji-Jun Chen

文献摘要

被引文献

相似文献

合成了一系列茜草醇A衍生物,并对其体外抗乙型肝炎病毒(HBV)活性和细胞毒性进行了评价。初步研究表明,对艾里索A的亲本结构进行简单的修饰可以产生许多潜在的重要的抗HBV衍生物。其中抗HBV活性最高的化合物6a对HBV表面抗原(IC50=0.024mM)、HBV e抗原(IC50=0.028mM)的分泌具有较高的抑制活性,对SIHBsAg >08、SIHBeAg bbb93的选择性指标也有显著的抑制作用,可作为一种新型的HBV抑制剂进行进一步评价。
A series of alisol A derivatives were synthesized and evaluated for their anti-hepatitis B virus (HBV) activities and cytotoxicities in vitro. The preliminary investigation demonstrates that simple modifications of the parent structure of alisol A can produce a number of potentially important derivatives against HBV. The most active anti-HBV compound 6a showed high activities against the secretion of HBV surface antigen (IC50=0.024mM), HBV e antigen (IC50=0.028mM) and remarkable selective indices (SIHBsAg>108, SIHBeAg>93), which was selected for further evaluation as a novel HBV inhibitor.